Sebaco HCT Tablet 10/40/12.5mg

Adult dose

This medication should be taken once daily, with or without food, along with water. It is recommended to take it at the same time each day (e.g., morning). The recommended dosages are as follows: - 5/20/12.5mg: Administered to patients whose blood pressure is not adequately controlled with amlodipine/olmesartan medoxomil 5/20mg combination therapy. - 5/40/12.5mg: Administered to those with amlodipine/olmesartan medoxomil 5/40mg.

Child dose

The safety and efficacy of this medication in pediatric patients under 18 years have not been established, therefore administration is not recommended.

This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. It should not be taken by patients with allergies to this medication or its components, certain heart diseases, severely impaired kidney or liver function, pregnant or nursing women, and patients with specific electrolyte imbalances. In patients with reduced blood volume or low salt levels, hypotension may occur; therefore, their condition should be carefully checked before administration, and appropriate measures should be taken if hypotensive symptoms appear. Patients with impaired kidney function, kidney transplant recipients, renovascular hypertension patients, liver disease patients, and patients with certain heart valve diseases should use this medication cautiously and undergo regular blood tests and physical assessments. This drug lowers blood pressure; hence, dizziness or lightheadedness may occur, requiring caution while driving or operating hazardous machinery. This medication has the potential for interactions with various drugs; therefore, if taking other medications, it is essential to inform and consult with a doctor or pharmacist. In case of overdose, symptoms such as hypotension and palpitations may appear, so it is essential to strictly adhere to the recommended dosage and immediately inform medical personnel of any abnormal symptoms. The safety and efficacy of this medication in children have not been established, making it not recommended, and the dosage should be adjusted for older adults, considering possible kidney function decline. Store this medication out of reach of children and protect it from moisture, heat, and direct sunlight.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, mouth/eye mucosal pain, shortness of breath or difficulty breathing, asthma attacks, cough with fever and respiratory abnormalities, yellowing of skin or eyes (jaundice), severe lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, vision disturbances, paralysis, urinary retention

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication may be sensitive to air or humidity, so it should be stored in a tightly sealed container. It is advisable to maintain storage temperatures between 1°C and 30°C at room temperature to preserve its efficacy and safety for a longer duration.

Appearance

Grayish-red round film-coated tablets

Package unit

30 tablets/box [10 tablets/Alu-Alu*3]